Akari Therapeutics Plc - American Depositary Shares (AKTX)

Last Price10.94

Change-1.06 (-8.83%)

NASDAQ· Last Trade: Jun 21st, 5:04 AM EDT

Detailed Quote

Previous Close	12.00
Open	12.02
Bid	10.00
Ask	10.99
Day's Range	10.61 - 12.80
52 Week Range	3.015 - 49.60
Volume	67,632
Market Cap	713.61B
PE Ratio (TTM)	-1,094.00
EPS (TTM)	-0.0
Dividend & Yield	N/A (N/A)
1 Month Average Volume	2,316,552

About Akari Therapeutics Plc - American Depositary Shares (AKTX)

Akari Therapeutics is a biotechnology company focused on developing innovative therapies for the treatment of rare and serious diseases. The company is primarily engaged in advancing its pipeline of proprietary drug candidates that target various conditions, including autoimmune disorders and other inflammatory diseases. Akari's approach combines advanced scientific research with a commitment to transforming patient care through novel treatment options. By leveraging its expertise in immunology and drug development, Akari aims to bring potentially life-changing therapies to market, addressing unmet medical needs and improving the quality of life for patients. Read More

Akari Therapeutics Plc - American Depositary Shares (AKTX)

Detailed Quote

Chart

About Akari Therapeutics Plc - American Depositary Shares (AKTX)

News & Press Releases